United Therapeutics UTHR
NASDAQ UTHR
$587.50 +2.71 (+0.46%)
At close: Oct 23, 2026 · 4:00 PM EDT

United Therapeutics (UTHR) Sale and Maturity of Investments (2009 - 2026)

Updated

Analysis

United Therapeutics (UTHR) Sale and Maturity of Investments (2009 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Investments Sold (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn -
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 308.00 Mn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn -
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 1.30 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 136.00 Mn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn -
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn -
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 1.03 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 2.12 Bn
10 United Therapeutics 25.07 Bn 14.57 Bn 683.80 Mn 265.30 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 265.30 Mn
Mar 31, 2026 1.58 Bn
Dec 31, 2025 485.50 Mn
Sep 30, 2025 778.50 Mn
Jun 30, 2025 1.57 Bn
Mar 31, 2025 611.70 Mn
Dec 31, 2024 478.00 Mn
Sep 30, 2024 387.20 Mn
Jun 30, 2024 196.50 Mn
Mar 31, 2024 1.31 Bn
Dec 31, 2023 526.70 Mn
Sep 30, 2023 407.70 Mn
Jun 30, 2023 493.20 Mn
Mar 31, 2023 709.70 Mn
Dec 31, 2022 277.20 Mn
Sep 30, 2022 246.30 Mn
Jun 30, 2022 378.50 Mn
Mar 31, 2022 131.90 Mn
Dec 31, 2021 371.70 Mn
Sep 30, 2021 308.60 Mn
API Access

United Therapeutics Sale and Maturity of Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=UTHR&period=max&api_key=YOUR_API_KEY